Department of Hematology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, China.
Immunol Lett. 2012 Feb 29;142(1-2):48-54. doi: 10.1016/j.imlet.2011.12.005. Epub 2012 Jan 12.
Disbalance of Th1 and Th17 can lead to inflammatory diseases and autoimmunity. Acute graft-versus-host disease (GVHD) is now considered as a compound and dysregulated immune response. Both Th1 and Th17 have been implicated in the pathophysiology of acute GVHD. Disbalance of Th1 and Th17 may also play a critical role in mediating acute GVHD. In this study, we investigated the Th1/Th17 imbalance in peripheral blood through out the pathological process of acute GVHD, using a GVHD model of C57BL/6 (H-2(b)) donor to BALB/c (H-2(d)) recipient. We also analyzed the correlation between Th1/Th17 ratio and severity of acute GVHD, and explored the potential function of Th1/Th17 imbalance in acute GVHD. Recipients received 5×10(6) spleen cells (SP) underwent more severe acute GVHD, compared with the ones received 5×10(5) SP. Severe GVHD bearing recipients had much higher proportion of Th1 cells but lower proportion of Th17 cells, compared with mild GVHD bearing ones. The Th1/Th17 ratios in both groups underwent relative changes according to the changing proportions of Th1 and Th17 cells and showed positive correlation with clinical scores of acute GVHD. We describe the changing proportions of Th1 and Th17 cells in acute GVHD, and we find that Th1/Th17 ratio is an accurate indicator for predicting the severity of acute GVHD.
Th1 和 Th17 失衡可导致炎症性疾病和自身免疫。急性移植物抗宿主病(GVHD)现在被认为是一种复合的、失调的免疫反应。Th1 和 Th17 都与急性 GVHD 的病理生理学有关。Th1 和 Th17 的失衡也可能在介导急性 GVHD 中发挥关键作用。在这项研究中,我们通过 C57BL/6(H-2(b))供体至 BALB/c(H-2(d))受者的 GVHD 模型,研究了外周血中 Th1/Th17 失衡在急性 GVHD 病理过程中的变化。我们还分析了 Th1/Th17 比值与急性 GVHD 严重程度的相关性,并探讨了 Th1/Th17 失衡在急性 GVHD 中的潜在作用。与接受 5×10(5)个脾细胞(SP)的受者相比,接受 5×10(6)个 SP 的受者发生更严重的急性 GVHD。与轻度 GVHD 受者相比,严重 GVHD 受者的 Th1 细胞比例较高,而 Th17 细胞比例较低。两组的 Th1/Th17 比值根据 Th1 和 Th17 细胞比例的变化而发生相对变化,并与急性 GVHD 的临床评分呈正相关。我们描述了急性 GVHD 中 Th1 和 Th17 细胞的比例变化,发现 Th1/Th17 比值是预测急性 GVHD 严重程度的准确指标。